Algorithm for drug treatment of stable angina with antianginal drugs to relieve symptoms and improve quality of life. Details, levels of recommendation and evidence level: see the corresponding text.
Algorithm for reduction of cardiovascular events in the presence of left ventricular dysfunction. Details, levels of recommendation and evidence level: see the corresponding text. ASA: Acetylsalicylic acid; AH: Arterial hypertension; ACE inhibitors: Angiotensin-converting enzyme inhibitors; ARB: Angiotensin receptor blocker I; AP: Arterial pressure; HR: Heart rate.
Percutaneous coronary intervention (PCI) or coronary-artery bypass grafting (CABG) in stable coronary atheroscleroctic disease without involvement of left main coronary artery. a≥ 50% stenosis and confirmation of ischemia, lesion > 90% confirmed by two physicians or fractional flow reserve of 0.80; bCABG is the preferred option in most patients, unless in case of comorbidities or other particularities that require discussion with the Heart Team. Adapted from: 2010 Guidelines on myocardial revascularization of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery.
Comments are moderated by the editorial team before publication. Discussions should be evidence-based and use scientific language. Conflicts of interest should be declared.
Comments are moderated by the editorial team before publication. Discussions should be evidence-based and use scientific language. Conflicts of interest should be declared.